Serono and NovImmune to Collaborate in Development of Two Novel Treatments for Autoimmune Diseases
Two Swiss companies have entered into an agreement. Well-known Serono will license drugs from Novimmune, a Geneva-based product development company focusing on immune mechanisms in order to clinically impact Immune Related Diseases, Inflammation and Organ transplantation.
Serono and NovImmune to Collaborate in Development of Two Novel Treatments for Autoimmune Diseases